Abstract: The present application relates to novel peptide-based compounds, optionally comprising an immunoactive built-in adjuvant, compositions comprising these compounds and their use, in particular for the treatment of diseases, disorders or conditions characterized by or associated with ?-amyloid accumulation. In particular, the present application includes compounds of Formula I, and compositions and uses thereof: [Ra-NP]m-Lp (I).
Type:
Grant
Filed:
July 24, 2013
Date of Patent:
August 1, 2017
Assignee:
MANUS PHARMACEUTICALS (CANADA) LTD.
Inventors:
Vladislav Deigin, Olga Volpina, Natalia Bobkova
Abstract: The invention relates to novel multifunctional bioactive compounds of the formula I: pharmaceutical compositions comprising these compounds and methods of using these compounds, in particular as therapeutic agents for the treatment of immune disorders.
Abstract: The invention relates to novel multifunctional bioactive compounds, pharmaceutical compositions comprising these compounds and methods of using these compounds, in particular as therapeutic agents.
Abstract: The present invention discloses multifunctional bioactive compounds of formula (I) constituted of an immunoregulatory portion linked to a stabilizer moiety and pharmaceutical compositions thereof useful in the treatment of immune disorders and hemopoietic disorders such as immune cytopema, multiple myeloma, chronic lymphoid leucosis, lymphocytic lymphomas, lymphosarcomas.